格鲁吉亚丙型肝炎感染及治疗状态与新型冠状病毒病2019相关住院的关系
该研究分析格鲁吉亚2020—2021年COVID-19阳性者健康登记数据,按HCV感染及治疗状态分组,用逻辑回归评估关联强度。结果显示,已治疗HCV者COVID-19相关住院的比值低于抗-HCV阴性者,而未治疗HCV病毒血症者和抗-HCV阳性非病毒血症者比值较高。结论认为COVID-19感染前接受HCV治疗与较低的COVID-19相关住院比值相关。
要点
- 已治疗HCV者COVID-19相关住院的比值低于抗-HCV阴性者。
- 未治疗HCV病毒血症者COVID-19相关住院的比值高于抗-HCV阴性者。
- 抗-HCV阳性非病毒血症者COVID-19相关住院的比值高于抗-HCV阴性者。
核心结论
- COVID-19感染前接受HCV治疗与较低的COVID-19相关住院比值相关,凸显大流行背景下HCV管理的益处。
研究设计与样本
- 分析格鲁吉亚2020—2021年COVID-19阳性个体健康登记数据,按HCV感染及治疗状态分类,采用逻辑回归评估关联强度。
主要发现
- 已治疗HCV者COVID-19相关住院的比值低于抗-HCV阴性者。
- 未治疗HCV病毒血症者COVID-19相关住院的比值高于抗-HCV阴性者。
- 抗-HCV阳性非病毒血症者COVID-19相关住院的比值高于抗-HCV阴性者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to evaluate the impact of hepatitis C virus (HCV) infection and treatment status on coronavirus disease 2019 (COVID-19)-related hospitalizations in Georgia. METHODS: We analyzed 2020-2021 Georgian health registry data for COVID-19-positive individuals and categorized the data by HCV infection and treatment status. Logistic regression was used to assess the strengths of the associations. RESULTS: Treated individuals with HCV had lower odds of COVID-19-related hospitalization compared to anti-HCV-negative individuals, while untreated HCV-viremic and anti-HCV-positive nonviremic individuals had higher odds. CONCLUSIONS: HCV treatment prior to COVID-19 infection was associated with lower odds of COVID-19-related hospitalization, highlighting the benefits of HCV management in the context of the pandemic.
引用
- Aslanikashvili A, Rylander C, Manjavidze T, et al. Relationship Between Hepatitis C Infection and Treatment Status and Coronavirus Disease 2019-Related Hospitalizations in Georgia. J Infect Dis. 2024. PMID: 38427715. doi:10.1093/infdis/jiae103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。